SmPC - Perindopril 8mg Tablets: Change history
View Summary of Product Characteristics (SmPC - Perindopril 8mg Tablets)
Last updated on this site: 17 Dec 2025
Description of update: To update section 4.4 of the SPC and section 2 of the PIL to bring in line with MHRA request: delayed onset of angioedema and angiotensin converting enzyme (ACE) inhibitors.
Date of approval: 20/11/2025
SmPC sections updated: 4.4 and 10
Last updated on this site: 17 Dec 2025
Description of update: To update section 4.4 of the SPC and section 2 of the PIL to bring in line with MHRA request: delayed onset of angioedema and angiotensin converting enzyme (ACE) inhibitors.
Date of approval: 20/11/2025
SmPC sections updated: 4.4 and 10
-
Changes: (Updated: 17 Dec 2025)
Description of update: To update section 4.4 of the SPC and section 2 of the PIL to bring in line with MHRA request: delayed onset of angioedema and angiotensin converting enzyme (ACE) inhibitors.
Date of approval: 20/11/2025
SmPC sections updated: 4.4 and 10
-
Changes: (Updated: 12 Jan 2023)
Update: To update sections 4.3, 4.4, 4.6, 5.1 and 5.3 of the SmPC and sections 2, 4 and 6 of the PIL for Perindopril 2 mg, 4 mg and 8 mg Tablets in line with the reference product, Coversyl film coated tablets by MAH Les Laboratories Servier.
-
Changes: (Updated: 21 Sep 2022)
Initial upload